DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -5.88%92.78M | 24.75%132.1M | 1.73%148.64M | 32.85%485.04M | 4.68%134.47M | 45.63%98.58M | 104.71%105.89M | 24.63%146.1M | 14.32%365.1M | 43.17%128.46M |
Net income from continuing operations | -2.58%73.28M | 5.35%67.97M | 107.20%247.19M | 21.11%340.79M | 2.26%81.76M | 44.23%75.22M | 12.49%64.52M | 29.77%119.3M | 43.60%281.39M | 64.21%79.95M |
Operating gains losses | -101.98%-24K | 125.00%2K | 176.92%10K | 172.85%1.25M | 137.33%56K | 733.51%1.21M | 97.13%-8K | 98.81%-13K | -231.20%-1.71M | 57.98%-150K |
Depreciation and amortization | 31.53%38.08M | 28.39%35.61M | 23.58%32.47M | 22.92%113.95M | 24.37%30.99M | 22.87%28.95M | 22.91%27.74M | 21.32%26.27M | 37.90%92.7M | 31.36%24.92M |
Deferred tax | 81.91%3.97M | -19.82%2.69M | -535.70%-10.49M | 179.66%2.56M | -181.67%-1.33M | -54.57%2.18M | 389.21%3.36M | 84.03%-1.65M | -109.76%-3.21M | -91.96%1.63M |
Other non cash items | 13.70%747K | -19.71%615K | -28.61%574K | 16.47%3.01M | 3.73%778K | -39.56%657K | 62.63%766K | 195.59%804K | 645.66%2.58M | 189.58%750K |
Change In working capital | -11.04%-47.42M | 104.35%1.12M | -3.61%-27.25M | -5.24%-105.79M | -329.57%-11.07M | -12.43%-42.7M | 51.48%-25.72M | -278.05%-26.3M | -36.56%-100.52M | 86.49%-2.58M |
-Change in receivables | -184.03%-542K | -102.30%-37K | -170.52%-3.56M | 147.94%6.4M | 88.75%-894K | -87.55%645K | 175.43%1.61M | 159.62%5.04M | -3,609.17%-13.35M | -326.15%-7.95M |
-Change in inventory | 1,023.08%438K | 608.16%249K | -52.73%182K | 200.00%224K | 39.84%-151K | -96.73%39K | 96.20%-49K | 210.48%385K | -146.57%-224K | -165.36%-251K |
-Change in prepaid assets | -78.60%375K | 253.42%5.54M | -98.85%-13.89M | -1.85%-6.62M | -52.66%2.23M | -38.46%1.75M | 60.69%-3.61M | -43.73%-6.98M | -10.59%-6.5M | 61.50%4.71M |
-Change in payables and accrued expense | 98.96%-176K | -38.23%18.62M | 13.17%-15.17M | 123.69%65.04M | 151.77%69.32M | -357.87%-16.96M | 990.16%30.14M | -803.99%-17.47M | -16.27%29.08M | 33.56%27.53M |
-Change in other current assets | 124.91%1.79M | 66.47%-4.02M | -80.43%572K | -212.30%-43.43M | -824.77%-35.17M | 116.58%795K | -412.40%-11.98M | 198.42%2.92M | -76.89%-13.91M | 55.43%-3.8M |
-Change in other working capital | -70.12%-49.3M | 54.01%-19.24M | 145.13%4.6M | -33.25%-127.41M | -103.39%-46.41M | 25.13%-28.98M | -2.46%-41.83M | -251.74%-10.2M | -0.95%-95.62M | 39.91%-22.82M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -5.88%92.78M | 24.75%132.1M | 1.73%148.64M | 32.85%485.04M | 4.68%134.47M | 45.63%98.58M | 104.71%105.89M | 24.63%146.1M | 14.32%365.1M | 43.17%128.46M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 27.02%-38.14M | 168.74%29.39M | 204.10%42.29M | -744.77%-196.71M | -798.58%-61.07M | -449.11%-52.26M | -194.78%-42.76M | 39.94%-40.62M | 90.96%-23.29M | 104.51%8.74M |
Net PPE purchase and sale | 7.75%-48.21M | -6.66%-45.61M | -17.47%-47.72M | -45.06%-192.47M | -39.84%-56.83M | -114.90%-52.26M | -28.61%-42.76M | -17.82%-40.62M | -9.93%-132.68M | -19.61%-40.64M |
Net intangibles purchase and sale | ---- | ---- | ---- | -3.01%-4.24M | ---- | ---- | ---- | ---- | 25.09%-4.12M | ---- |
Net investment purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 186.34%113.51M | ---- |
Net other investing changes | --10.07M | --75M | --90M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 27.02%-38.14M | 168.74%29.39M | 204.10%42.29M | -744.77%-196.71M | -798.58%-61.07M | -449.11%-52.26M | -194.78%-42.76M | 39.94%-40.62M | 90.96%-23.29M | 104.51%8.74M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -356.81%-928.88M | -28.56%-536.54M | 105.51%376.09M | -207.88%-274.66M | -64.05%163.03M | 87.87%-203.34M | 32.78%-417.35M | -91.28%183M | 53.62%254.59M | 140.55%453.46M |
Net issuance payments of debt | ---- | ---- | ---- | -10,004.53%-29M | ---- | ---- | ---- | ---- | 83.83%-287K | --0 |
Net common stock issuance | 43.94%-42.04M | ---- | ---- | -202.81%-286.62M | ---211.62M | ---74.99M | ---- | ---- | ---94.65M | --0 |
Cash dividends paid | 1.61%-21.29M | 2.48%-21.19M | ---21.21M | ---64.84M | ---21.47M | ---21.64M | ---21.73M | --0 | --0 | --0 |
Net other financing activities | -711.11%-865.56M | -9.85%-434.59M | 117.10%397.3M | -69.73%105.8M | -6.25%425.13M | 93.64%-106.71M | 24.84%-395.62M | -91.28%183M | 108.67%349.53M | 140.57%453.46M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -356.81%-928.88M | -28.56%-536.54M | 105.51%376.09M | -207.88%-274.66M | -64.05%163.03M | 87.87%-203.34M | 32.78%-417.35M | -91.28%183M | 53.62%254.59M | 140.55%453.46M |
Net cash flow | ||||||||||
Beginning cash position | 11.58%2.61B | 10.83%2.99B | 0.57%2.42B | 32.90%2.41B | 20.23%2.19B | -31.82%2.34B | -31.90%2.7B | 32.90%2.41B | 14.35%1.81B | -40.08%1.82B |
Current changes in cash | -456.74%-874.24M | -5.88%-375.05M | 96.55%567.02M | -97.71%13.67M | -59.97%236.43M | 90.30%-157.03M | 32.41%-354.23M | -86.57%288.49M | 162.25%596.4M | 148.33%590.66M |
End cash Position | -20.39%1.74B | 11.58%2.61B | 10.83%2.99B | 0.57%2.42B | 0.57%2.42B | 20.23%2.19B | -31.82%2.34B | -31.90%2.7B | 32.90%2.41B | 32.90%2.41B |
Free cash flow | -3.72%44.57M | 37.10%86.49M | -4.34%100.91M | 26.24%288.21M | -12.37%73.35M | 6.74%46.29M | 241.36%63.08M | 27.46%105.49M | 18.19%228.31M | 61.73%83.7M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |